Summary

The global market for Sitagliptin Tablet was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Sitagliptin is used along with diet and exercise and sometimes with other medications to lower blood sugar levels in adults with type 2 diabetes (condition in which blood sugar is too high because the body does not produce or use insulin normally).
North American market for Sitagliptin Tablet was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Sitagliptin Tablet was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Sitagliptin Tablet was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Sitagliptin Tablet include Merck, Pharmaffiliates, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Sitagliptin Tablet, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sitagliptin Tablet by region & country, by Type, and by Application.

The Sitagliptin Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sitagliptin Tablet.

Market Segmentation
By Company
Merck
Pharmaffiliates
Segment by Type
25mg
50mg
100mg
Segment by Application
Diabetes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sitagliptin Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Sitagliptin Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Sitagliptin Tablet in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Sitagliptin Tablet Product Introduction
1.2 Global Sitagliptin Tablet Market Size Forecast
1.2.1 Global Sitagliptin Tablet Sales Value (2020-2031)
1.2.2 Global Sitagliptin Tablet Sales Volume (2020-2031)
1.2.3 Global Sitagliptin Tablet Sales Price (2020-2031)
1.3 Sitagliptin Tablet Market Trends & Drivers
1.3.1 Sitagliptin Tablet Industry Trends
1.3.2 Sitagliptin Tablet Market Drivers & Opportunity
1.3.3 Sitagliptin Tablet Market Challenges
1.3.4 Sitagliptin Tablet Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sitagliptin Tablet Players Revenue Ranking (2024)
2.2 Global Sitagliptin Tablet Revenue by Company (2020-2025)
2.3 Global Sitagliptin Tablet Players Sales Volume Ranking (2024)
2.4 Global Sitagliptin Tablet Sales Volume by Company Players (2020-2025)
2.5 Global Sitagliptin Tablet Average Price by Company (2020-2025)
2.6 Key Manufacturers Sitagliptin Tablet Manufacturing Base and Headquarters
2.7 Key Manufacturers Sitagliptin Tablet Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Sitagliptin Tablet
2.9 Sitagliptin Tablet Market Competitive Analysis
2.9.1 Sitagliptin Tablet Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Sitagliptin Tablet Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sitagliptin Tablet as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 25mg
3.1.2 50mg
3.1.3 100mg
3.2 Global Sitagliptin Tablet Sales Value by Type
3.2.1 Global Sitagliptin Tablet Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Sitagliptin Tablet Sales Value, by Type (2020-2031)
3.2.3 Global Sitagliptin Tablet Sales Value, by Type (%) (2020-2031)
3.3 Global Sitagliptin Tablet Sales Volume by Type
3.3.1 Global Sitagliptin Tablet Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Sitagliptin Tablet Sales Volume, by Type (2020-2031)
3.3.3 Global Sitagliptin Tablet Sales Volume, by Type (%) (2020-2031)
3.4 Global Sitagliptin Tablet Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Diabetes
4.1.2 Others
4.2 Global Sitagliptin Tablet Sales Value by Application
4.2.1 Global Sitagliptin Tablet Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Sitagliptin Tablet Sales Value, by Application (2020-2031)
4.2.3 Global Sitagliptin Tablet Sales Value, by Application (%) (2020-2031)
4.3 Global Sitagliptin Tablet Sales Volume by Application
4.3.1 Global Sitagliptin Tablet Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Sitagliptin Tablet Sales Volume, by Application (2020-2031)
4.3.3 Global Sitagliptin Tablet Sales Volume, by Application (%) (2020-2031)
4.4 Global Sitagliptin Tablet Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Sitagliptin Tablet Sales Value by Region
5.1.1 Global Sitagliptin Tablet Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Sitagliptin Tablet Sales Value by Region (2020-2025)
5.1.3 Global Sitagliptin Tablet Sales Value by Region (2026-2031)
5.1.4 Global Sitagliptin Tablet Sales Value by Region (%), (2020-2031)
5.2 Global Sitagliptin Tablet Sales Volume by Region
5.2.1 Global Sitagliptin Tablet Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Sitagliptin Tablet Sales Volume by Region (2020-2025)
5.2.3 Global Sitagliptin Tablet Sales Volume by Region (2026-2031)
5.2.4 Global Sitagliptin Tablet Sales Volume by Region (%), (2020-2031)
5.3 Global Sitagliptin Tablet Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Sitagliptin Tablet Sales Value, 2020-2031
5.4.2 North America Sitagliptin Tablet Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Sitagliptin Tablet Sales Value, 2020-2031
5.5.2 Europe Sitagliptin Tablet Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Sitagliptin Tablet Sales Value, 2020-2031
5.6.2 Asia Pacific Sitagliptin Tablet Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Sitagliptin Tablet Sales Value, 2020-2031
5.7.2 South America Sitagliptin Tablet Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Sitagliptin Tablet Sales Value, 2020-2031
5.8.2 Middle East & Africa Sitagliptin Tablet Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sitagliptin Tablet Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Sitagliptin Tablet Sales Value
6.2.1 Key Countries/Regions Sitagliptin Tablet Sales Value, 2020-2031
6.2.2 Key Countries/Regions Sitagliptin Tablet Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Sitagliptin Tablet Sales Value, 2020-2031
6.3.2 United States Sitagliptin Tablet Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Sitagliptin Tablet Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Sitagliptin Tablet Sales Value, 2020-2031
6.4.2 Europe Sitagliptin Tablet Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Sitagliptin Tablet Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Sitagliptin Tablet Sales Value, 2020-2031
6.5.2 China Sitagliptin Tablet Sales Value by Type (%), 2024 VS 2031
6.5.3 China Sitagliptin Tablet Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Sitagliptin Tablet Sales Value, 2020-2031
6.6.2 Japan Sitagliptin Tablet Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Sitagliptin Tablet Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Sitagliptin Tablet Sales Value, 2020-2031
6.7.2 South Korea Sitagliptin Tablet Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Sitagliptin Tablet Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Sitagliptin Tablet Sales Value, 2020-2031
6.8.2 Southeast Asia Sitagliptin Tablet Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Sitagliptin Tablet Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Sitagliptin Tablet Sales Value, 2020-2031
6.9.2 India Sitagliptin Tablet Sales Value by Type (%), 2024 VS 2031
6.9.3 India Sitagliptin Tablet Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Introduction and Business Overview
7.1.3 Merck Sitagliptin Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Merck Sitagliptin Tablet Product Offerings
7.1.5 Merck Recent Development
7.2 Pharmaffiliates
7.2.1 Pharmaffiliates Company Information
7.2.2 Pharmaffiliates Introduction and Business Overview
7.2.3 Pharmaffiliates Sitagliptin Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Pharmaffiliates Sitagliptin Tablet Product Offerings
7.2.5 Pharmaffiliates Recent Development
8 Industry Chain Analysis
8.1 Sitagliptin Tablet Industrial Chain
8.2 Sitagliptin Tablet Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sitagliptin Tablet Sales Model
8.5.2 Sales Channel
8.5.3 Sitagliptin Tablet Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer